Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer

BACKGROUND: Colon cancer (CC) is a heterogeneous disease. Novel prognostic factors beyond pathological staging are required to accurately identify patients at higher risk of relapse. Integrating these new biological factors, such as plasma circulating tumour DNA (ctDNA), CDX2 staining, inflammation-...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarazona, Noelia, Gimeno-Valiente, Francisco, Gambardella, Valentina, Huerta, Marisol, Roselló, Susana, Zuniga, Sheila, Calon, Alexandre, Carbonell-Asins, Juan Antonio, Fontana, Elisa, Martinez-Ciarpaglini, Carolina, Eason, Katherine, Rentero-Garrido, Pilar, Fleitas, Tania, Papaccio, Federica, Moro-Valdezate, David, Nyamundanda, Gift, Castillo, Josefa, Espí, Alejandro, Sadanandam, Anguraj, Roda, Desamparados, Cervantes, Andrés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513635/
https://www.ncbi.nlm.nih.gov/pubmed/32967918
http://dx.doi.org/10.1136/esmoopen-2020-000847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513635/
https://www.ncbi.nlm.nih.gov/pubmed/32967918
http://dx.doi.org/10.1136/esmoopen-2020-000847

Ejemplares similares